Theravance (THRX) is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. This stock is trading up 17.9% at $23 in recent trading.
Today's Volume: 849,000Average Volume: 689,326 Volume % Change: 222% Shares of THRX are soaring today on news that partner GlaxoSmithKline (GSK) plans to increase its stake in the biotech group from 18.3% to 26.8%. From a technical perspective, THRX is ripping higher today on above average volume. This move is quickly pushing THRX within range of triggering a big breakout trade. That trade will hit once THRX takes out some past overhead resistance levels at $24.27 to $25.40 with high-volume. Traders should look for long-biased trades if THRX can manage to move and close above those levels on volume that's near or well above 689,326 shares. If we get that action soon, watch for THRX to re-test its next significant overhead resistance levels at $27 to $28.95 in the near future. Theravance is one of the top holdings of Seth Klarman's Baupost Group, which has a 14.2 million-share position in the stock as of the most recently reported quarter.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV